Research letterDuality of Netherton syndrome manifestations and response to ixekizumab
References (5)
- et al.
An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis
J Allergy Clin Immunol
(2017) - et al.
The major orphan forms of ichthyosis are characterized by systemic T-cell activation and Th-17/Tc-17/Th-22/Tc-22 polarization in blood
J Invest Dermatol
(2018)
Cited by (21)
Secukinumab: A life-changing treatment for Netherton syndrome?
2023, Annales de Dermatologie et de VenereologieAtopy as Immune Dysregulation: Offender Genes and Targets
2022, Journal of Allergy and Clinical Immunology: In PracticeUnderstanding immune profiles in ichthyosis may lead to novel therapeutic targets
2022, Journal of Allergy and Clinical ImmunologyNetherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
2022, Journal of Allergy and Clinical ImmunologyCitation Excerpt :IL-17 and IL-36 cytokines trigger epidermal proliferation32,33 and inhibit epidermal differentiation in psoriasis.34,35 We previously reported, and confirmed in this study, that lesion NS-ILC skin displayed marked neutrophil infiltrates, whereas lesion NS-SE skin was mainly infiltrated with mast cells.27 Neutrophil gelatinase–associated lipocalin and histamine released by mast cells could participate in the dysregulation of epidermal differentiation in NS-ILC and NS-SE patients, respectively.36,37
Biologics for inherited disorders of keratinisation: A systematic review
2024, Australasian Journal of DermatologyNetherton syndrome in a Bulgarian patient: Presentation of a case and an update of therapeutic options
2023, Wiener Medizinische Wochenschrift
Dr Barbieux and Author Bonnet des Claustres contributed equally to this article.
Funding sources: Supported by the National Research Agency (ANR-17-CE14-0025-03 Tfh Atopy and ANR-19-CE17-0017-01TARGET-NS) and Imagine Institute (Cross-Lab Project). State funding from the Agence Nationale de la Recherche under “Investissements d’avenir” program (ANR-10-IAHU-01).
Conflicts of interest: None disclosed.
IRB approval status: Reviewed and approved by the IRB of Assistance Publique, Hôpitaux de Paris, France.
Reprints not available from the authors.